Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...
SOUTH SAN FRANCISCO, Calif. & TOKYO--(BUSINESS WIRE)--Cellares, the world’s first Integrated Development and Manufacturing Organization (IDMO) and a leader in automated cell therapy manufacturing, and ...
What are cell and gene therapies? Cell and gene therapies are used to treat, and sometimes cure, diseases by addressing the underlying genes or proteins. While there is overlap between the fields, ...
The past decade has seen an explosion in the number of antibody-based therapeutics on the market. A huge driver of this has been the advancement of technologies that improve the time and efficiency of ...
Multiplexed, multiparameter screening assays are foundational to the drug discovery process. By collecting more information, more rapidly – whether the focus antibodies, small molecules, or phenotypic ...
Researchers normally employ several analytical instruments to assess complex cell-based assays. However, advanced flow cytometers can measure numerous parameters, such as cell viability, ...
Flow cytometry is a strong analytical method that is utilized to determine, measure, and examine cells and particles in a heterogeneous mixture. The standard instrument comprises three primary ...
Antibody-based therapeutics are helping patients across a wide range of disease areas, from cancer, such as Rituximab treatment of CD20-positive non-Hodgkin's lymphomas, to infectious diseases like ...
What are cell and gene therapies? Cell and gene therapies are utilized to treat diseases and, in some cases, cure diseases by targeting the underlying proteins or genes. Overlaps between these ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the global commercial launch of BD Research Cloud 7.0, marking another step forward in its AI-driven life sciences strategy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results